|
🦁
|
Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study.
M. Tominaga,
H. Eguchi,
H. Manaka,
K. Igarashi,
T. Kato,
A. Sekikawa
|
10 |
1999 |
10
🦁
|
|
🐜
|
International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values
23 auth.
A. Kashiwagi,
M. Kasuga,
E. Araki,
Y. Oka,
T. Hanafusa,
Hiroshi Ito,
M. Tominaga,
S. Oikawa,
Mitsuhiko Noda,
T. Kawamura,
...
T. Sanke,
M. Namba,
M. Hashiramoto,
T. Sasahara,
Y. Nishio,
K. Kuwa,
K. Ueki,
I. Takei,
M. Umemoto,
M. Murakami,
M. Yamakado,
Y. Yatomi,
H. Ohashi
|
9 |
2012 |
9
🐜
|
|
🐜
|
Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts.
33 auth.
Q. Qiao,
G. Hu,
J. Tuomilehto,
T. Nakagami,
B. Balkau,
K. Borch-Johnsen,
A. Ramachandran,
V. Mohan,
S. R. Iyer,
M. Tominaga,
Y. Kiyohara,
I. Kato,
K. Okubo,
M. Nagai,
S. Shibazaki,
...
Ze Yang,
Zhifu Tong,
Qinying Fan,
B. Wang,
S. Chew,
B. Tan,
D. Heng,
S. Emmanuel,
N. Tajima,
Y. Iwamoto,
C. Snehalatha,
V. Vijay,
A. Kapur,
Yanhu Dong,
H. Nan,
Weiguo Gao,
Haiyan Shi,
Fangming Fu
|
8 |
2003 |
8
🐜
|
|
🐜
|
Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study.
10 auth.
M. Daimon,
T. Oizumi,
T. Saitoh,
W. Kameda,
A. Hirata,
H. Yamaguchi,
...
H. Ohnuma,
M. Igarashi,
M. Tominaga,
T. Kato
|
8 |
2003 |
8
🐜
|
|
🐜
|
Prevention of type 2 diabetes in a primary healthcare setting: Three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance
15 auth.
N. Sakane,
J. Sato,
K. Tsushita,
S. Tsujii,
K. Kotani,
K. Tsuzaki,
M. Tominaga,
S. Kawazu,
Yuzo Sato,
T. Usui,
...
I. Kamae,
Toshihide Yoshida,
Y. Kiyohara,
Shigeaki Sato,
H. Kuzuya
|
7 |
2011 |
7
🐜
|
|
🐜
|
Cardiovascular risk factors and retinal microvascular signs in an adult Japanese population: the Funagata Study.
13 auth.
R. Kawasaki,
Jie-Jin Wang,
E. Rochtchina,
B. Taylor,
T. Wong,
M. Tominaga,
T. Kato,
M. Daimon,
T. Oizumi,
S. Kawata,
...
T. Kayama,
H. Yamashita,
P. Mitchell
|
6 |
2006 |
6
🐜
|
|
🐜
|
Prevalence of Diabetes and Impaired Glucose Tolerance in Funagata Area, Japan
11 auth.
A. Sekikawa,
M. Tominaga,
Kenji Takahashi,
H. Eguchi,
M. Igarashi,
H. Ohnuma,
...
K. Sugiyama,
H. Manaka,
H. Sasaki,
H. Fukuyama,
K. Miyazawa
|
6 |
1993 |
6
🐜
|
|
🐜
|
Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes? Japan National Diabetes Survey.
7 auth.
T. Nakagami,
M. Tominaga,
R. Nishimura,
N. Yoshiike,
M. Daimon,
T. Oizumi,
...
N. Tajima
|
6 |
2007 |
6
🐜
|
|
🐜
|
Pioglitazone (AD-4833) ameliorates insulin resistance in patients with NIDDM. AD-4833 Glucose Clamp Study Group, Japan.
16 auth.
Y. Yamasaki,
R. Kawamori,
T. Wasada,
A. Sato,
Y. Omori,
H. Eguchi,
M. Tominaga,
H. Sasaki,
M. Ikeda,
M. Kubota,
...
Y. Ishida,
T. Hozumi,
S. Baba,
M. Uehara,
M. Shichiri,
Toshio Kaneko
|
6 |
1997 |
6
🐜
|
|
🐜
|
Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg polymorphism of the beta(3)-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample.
11 auth.
T. Oizumi,
M. Daimon,
T. Saitoh,
W. Kameda,
H. Yamaguchi,
H. Ohnuma,
...
M. Igarashi,
H. Eguchi,
H. Manaka,
M. Tominaga,
T. Kato
|
6 |
2001 |
6
🐜
|
|
🐜
|
Progression of diabetic nephropathy enhances the plasma osteopontin level in type 2 diabetic patients.
11 auth.
H. Yamaguchi,
M. Igarashi,
A. Hirata,
H. Tsuchiya,
K. Sugiyama,
Yoshihiro Morita,
...
Y. Jimbu,
H. Ohnuma,
M. Daimon,
M. Tominaga,
T. Kato
|
6 |
2004 |
6
🐜
|
